Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study

References

• SorliCHeileMKIdentifying and meeting the challenges of insulin therapy in type 2 diabetesJ Multidiscip Healthc2014726728225061317
   PubMedGoogle Scholar
• WrightABurdenACPaiseyRBCullCAHolman RR;UK. Prospective Diabetes Study Group. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)Diabetes Care200225233033611815505
   PubMed Web of Science ®Google Scholar
• Del PratoSPennoGMiccoliRChanging the treatment paradigm for type 2 diabetesDiabetes Care200932suppl 2217222
   PubMed Web of Science ®Google Scholar
• PeyrotMBarnettAHMeneghiniLFSchumm-DraegerPMInsulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy studyDiabet Med201229568268922313123
   PubMed Web of Science ®Google Scholar
• MorrisADBoyleDIMcMahonADGreeneSAMacDonaldTMNewtonRWAdherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring UnitLancet19973509090150515109388398
   PubMed Web of Science ®Google Scholar
• AronsonRThe role of comfort and discomfort in insulin therapyDiabetes Technol Ther201214874174722537418
   PubMed Web of Science ®Google Scholar
• Pharmafile [webpage on the Internet]Treatment Flexibility Will Improve Adherence in Diabetes, Study Suggests. Findings from Global Attitudes of Patients and Physicians in Insulin Therapy Study Available from: http://www.pharmafile.com/news/161079/treatment-flexibility-will-improve-adherence-diabetes-study-suggestsAccessed April 7, 2015
   Google Scholar
• SpannSJNuttingPAGalliherJMManagement of type 2 diabetes in the primary care setting: a practice-based research network studyAnn Fam Med200641233116449393
   PubMed Web of Science ®Google Scholar
• BarnettAHMeneghiniLFSchumm-DraegerP-MPeyrotMThe GAPP (Global Attitudes of Patients and Physicians in Insulin Therapy) study: identifying risk factors associated with injection omission/non-adherence in insulin treated patients with type 1 and type 2 diabetesDiabet Med201229suppl 1168
   Google Scholar
• KarterAJSubramanianUSahaCBarriers to insulin initiation: the translating research into action for diabetes insulin starts projectDiabetes Care201033473373520086256
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRKrugerDFTravisLBCorrelates of insulin injection omissionDiabetes Care201033224024520103556
   PubMed Web of Science ®Google Scholar
• DaileyGKimMSLianJFPatient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitusClin Ther20012381311132011558867
   PubMed Web of Science ®Google Scholar
• BonafedeMMKalsekarAPawaskarMA retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixturesPatient Prefer Adherence2010414715620622915
   PubMed Web of Science ®Google Scholar
• YavuzDGOzcanSDeyneliOAdherence to insulin treatment in insulin-naive type 2 diabetic patients initiated on different insulin regimensPatient Prefer Adherence201591225123126346988
   PubMed Web of Science ®Google Scholar
• HermannsNMahrMKulzerBSkovlundSEHaakTBarriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal studyHealth Qual Life Outcomes2010811320920319
   PubMed Web of Science ®Google Scholar
• CramerJAA systematic review of adherence with medications for diabetesDiabetes Care20042751218122415111553
   PubMed Web of Science ®Google Scholar
• OliveriaSAMendittoLAUlcickas YoodMKooYHWellsKEMcCarthyBDBarriers to the initiation of, and persistence with, insulin therapyCurr Med Res Opin200723123105311217977482
   PubMed Web of Science ®Google Scholar
• OdegardPSCapocciaKMedication taking and diabetes: a systematic review of the literatureDiabetes Educ200733610141029 Discussion 1030–103118057270
   PubMed Web of Science ®Google Scholar
• KorytkowskiMBellDJacobsenCSuwannasariRFlexPen Study TeamA multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitusClin Ther200325112836284814693308
   PubMed Web of Science ®Google Scholar
• FloodTAdvances in insulin delivery systems and devices: beyond the vial and syringeInsulin2006199108
   Google Scholar
• BenroubiMFear, guilt feelings and misconceptions: barriers to effective insulin treatment in type 2 diabetesDiabetes Res Clin Pract201193suppl 1S97S9921864760
   PubMed Web of Science ®Google Scholar
• PetznickAMIdentifying and addressing barriers to insulin acceptance and adherence in patients with type 2 diabetes mellitusJ Am Osteopath Assoc20131134 suppl 2S6S1623545891
   PubMedGoogle Scholar
• American Diabetes AssociationStandards of medical care in diabetes – 2014Diabetes Care201437suppl 1S14S8024357209
   PubMed Web of Science ®Google Scholar
• el-KebbiIMZiemerDCGallinaDLDunbarVPhillipsLSDiabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocolsDiabetes Care1999221617162010526724
   PubMed Web of Science ®Google Scholar
• FreemantleNBalkauBHomePDA propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetesDiabetes Obes Metab201315121120112723782548
   PubMed Web of Science ®Google Scholar
• GiuglianoDMaiorinoMBellastellaGChiodiniPEspositoKRelationship of baseline HbA1c, HbA1c change and HbA1c target of <7% with insulin analogues in type 2 diabetes: a meta-analysis of randomized controlled trialsInt J Clin Pract201165560261221489084
   PubMed Web of Science ®Google Scholar
• RatnerRWynneANakhleSBruscoOVlajnicARendellMInfluence of preprandial vs postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096)Diabetes Obes Metab201113121142114821812890
   PubMed Web of Science ®Google Scholar
• GordonJPockettRDTetlowAPMcEwanPHomePDA comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database studyInt J Clin Pract201064121609161820946269
   PubMed Web of Science ®Google Scholar
• VergèsBBrunJMTawilCAlexandreBKerlanVStrategies for insulin initiation: insights from the French LIGHT observational studyDiabetes Metab Res Rev20122819710522218757
   PubMed Web of Science ®Google Scholar
• RodbardHWJellingerPSDavidsonJAStatement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic controlEndocr Pract200915654054919858063
   PubMed Web of Science ®Google Scholar
• LaSalleJREmpowering patients during insulin initiation: a real-world approachJ Am Osteopath Assoc20101102697820160245
   PubMedGoogle Scholar
• InzucchiSEBergenstalRMBuseJBAmerican Diabetes Association (ADA), European Association for the Study of Diabetes (EASD)Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes Care2012351364137922517736
   PubMed Web of Science ®Google Scholar